Andreas Humpe has been Medical Director of the Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology at LMU Medical Center since April 2018 and holds the W2 professorship in Transfusion Medicine and Cell Therapy at LMU. In this role, he serves as the qualified person under the German Medicines Act, oversees the manufacture of cell therapies, and is the hospital’s transfusion director.

Previously, he headed the Institute for Transfusion Medicine and Blood Bank at Magdeburg University Hospital, where he held a W3 professorship, and before that, the Institute for Transfusion Medicine at Leipzig University Hospital. From 2001 to 2016, he was a senior physician in the Division of Stem Cell and Immunotherapy at the University Medical Center Schleswig-Holstein in Kiel. There, he planned and certified the cleanroom laboratories at the Dr. Mildred Scheel House, obtained the manufacturing license in 2005, and, starting in 2007, was responsible for the GMP manufacturing of stem cells, T cells, and mesenchymal stem cells across the entire campus.

Humpe studied medicine in Münster, including a research fellowship at the Ontario Cancer Institute in Toronto, and completed his specialty training in transfusion medicine in Göttingen. He holds a subspecialty certification in quality management, completed his habilitation in Kiel in 2001, and was appointed adjunct professor there in 2014. As an inspector for the Joint Accreditation Committee ISCT–EBMT (JACIE), he has audited cell therapy centers. He headed the Stem Cell Transplantation and Cell Therapy Section of the German Society for Transfusion Medicine and Immunohematology and served as chairman of the Professional Association of German Transfusion Medicine Specialists (BDT) from 2024 to 2026.